Celldex Therapeutics
CLDX
#4718
Rank
NZ$2.87 B
Marketcap
$43.36
Share price
3.49%
Change (1 day)
-33.61%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.93

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.23. In 2022 the company made an earnings per share (EPS) of -$4.21 a decrease over its 2021 EPS that were of -$2.89.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.93-6.55%
2022-$4.2145.73%
2021-$2.89-23.36%
2020-$3.77-41.05%
2019-$6.40-76.95%
2018-$27.7545.03%
2017-$19.13-42.54%
2016-$33.30-3.82%
2015-$34.62-0.76%
2014-$34.8829.41%
2013-$26.960%
2012-$26.96-9.73%
2011-$29.861312.5%
2010-$2.11-95.79%
2009-$50.17-49.64%
2008-$99.63-82.64%
2007-$573.99-44.98%
2006-$1,0431270.83%
2005-$76.1133.33%
2004-$57.08-10%
2003-$63.42-16.67%
2002-$76.11-38.46%
2001-$123.68-4.88%
2000-$130.02-81.66%
1999-$708.77-87.2%
1998-$5,535206.39%
1997-$1,80713.02%
1996-$1,598

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$7.06 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.50-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$21.28 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.93-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.28-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.17-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$1.00-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA